Inactive Instrument
Immune Pharmaceuticals, Inc. Stock
Stocks
FZRQ
US45254C2008
Pharmaceuticals
OTC Markets Traded| 1 day | +300.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 2021-04-12 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 2017-12-10 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 2013-08-25 |
Daniel Kazado
CHM | Chairman | 61 | 2013-10-09 |
John A. Neczesny
BRD | Director/Board Member | 62 | 2016-02-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/3/20 | Sell | Director | 75,000 | 0.0412% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +300.00% | -.--% | - | - | 386K | |
| -0.67% | +5.66% | +75.21% | +125.34% | 1,119B | |
| +1.04% | +4.87% | +52.29% | +65.95% | 651B | |
| -0.17% | +6.04% | +25.60% | +79.85% | 468B | |
| -1.38% | +4.31% | +41.64% | +41.08% | 374B | |
| -0.52% | +3.53% | +24.32% | +40.27% | 302B | |
| -1.06% | +5.67% | +1.19% | +12.44% | 259B | |
| +1.03% | +6.90% | +51.11% | +72.46% | 238B | |
| -0.53% | +1.54% | -17.77% | -54.10% | 208B | |
| +0.42% | +6.06% | +27.86% | +90.47% | 181B | |
| Average | +29.80% | +5.17% | +31.27% | +52.64% | 422.21B | |
| Weighted average by Cap. | -0.16% | +5.40% | +43.93% | +72.03% |
Employees
7
Sector
Pharmaceuticals
